#ResearchNeverStops

EVT Execute

Our services

EVT Innovate

Our R&D initiatives

Action Plan

The data-driven R&D Autobahn to Cures

Science Pool

Evotec's new scientific content hub

Jobs

What you can contribute

IR & ESG

How you can participate

Highlights

Evotec Capital Markets Day - Paradigm Shift in Biologics

2 November 2022 in Redmond / Seattle

Click here for webcast recording

DDup 13

PanHunter: Evotec's next-generation multi-omics data analysis platform

Just - Evotec Biologics' J.POD® wins CPhI Pharma Award 2022

DDup 12

Evotec`s 3D cell model platform

News View all news

EVT801 pre-clinical data published in peer-reviewed cancer research journal

Sydney, Australia, 01 Dec 2022

Evotec partner Kazia Therapeutics Limited, an oncology-focused drug development company, announced the publication of positive...

Read more

Evotec substiantially reduces carbon emissions by joining renewable energy heating network

Hamburg, Germany, 30 Nov 2022

Evotec SE announced today that the Company will substantially reduce its carbon emissions by joining the renewable energy heating...

Read more

IR & ESG Events View all events

9 January2023

10 January2023

ODDO BHF Forum Venue: Virtual
Organisers: ODDO BHF

28 March2023

Publication Preliminary Figures Full-year 2022

Company Presentation

Download our Company Presentation

December 2022

Download

TOP